{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T22:35:39Z","timestamp":1793486139988,"version":"4.5.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.ajog.2018.08.030","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T09:28:14Z","timestamp":1535448494000},"page":"57.e1-57.e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis"],"prefix":"10.1016","volume":"220","author":[{"given":"Reem","family":"Masarwa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bar-Oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einat","family":"Gorelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimon","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amichai","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-9258","authenticated-orcid":false,"given":"Ilan","family":"Matok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2018.08.030_bib1","first-page":"1","article-title":"Perinatal depression: prevalence, screening accuracy, and screening outcomes","volume":"119","author":"Gaynes","year":"2005","journal-title":"Evid Rep Technol Assess (Summ)"},{"key":"10.1016\/j.ajog.2018.08.030_bib2","first-page":"153","article-title":"Trends in prescribing of selective serotonin reuptake inhibitors and other newer antidepressant agents in adult primary care","volume":"5","author":"Pirraglia","year":"2003","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"10.1016\/j.ajog.2018.08.030_bib3","doi-asserted-by":"crossref","first-page":"e0144474","DOI":"10.1371\/journal.pone.0144474","article-title":"Use of\u00a0SSRI and SNRI antidepressants during pregnancy: a population-based study from Denmark, Iceland, Norway and Sweden","volume":"10","author":"Zoega","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2018.08.030_bib4","doi-asserted-by":"crossref","first-page":"544.e1","DOI":"10.1016\/j.ajog.2007.01.033","article-title":"Increasing use of antidepressants in pregnancy","volume":"196","author":"Cooper","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.08.030_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4088\/JCP.12r07968","article-title":"The impact of maternal depression during pregnancy on perinatal outcomes: a systematic review and meta-analysis","volume":"74","author":"Grigoriadis","year":"2013","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2018.08.030_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s40262-014-0233-3","article-title":"Placental transfer of antidepressant medications: implications for postnatal adaptation syndrome","volume":"54","author":"Ewing","year":"2016","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2018.08.030_bib7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1176\/appi.ajp.160.5.993","article-title":"Placental passage of antidepressant medications","volume":"160","author":"Hendrick","year":"2003","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ajog.2018.08.030_bib8","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0163-7258(99)00048-0","article-title":"Pharmacokinetics of selective serotonin reuptake inhibitors","volume":"85","author":"Hiemke","year":"2000","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.ajog.2018.08.030_bib9","doi-asserted-by":"crossref","first-page":"49.e1","DOI":"10.1016\/j.ajog.2012.04.028","article-title":"Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies","volume":"207","author":"Hayes","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2018.08.030_bib10","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa1312828","article-title":"Antidepressant use in pregnancy and the risk of cardiac defects","volume":"370","author":"Huybrechts","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.08.030_bib11","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/archpedi.160.2.173","article-title":"Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants","volume":"160","author":"Levinson-Castiel","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.ajog.2018.08.030_bib12","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/bcp.13194","article-title":"SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn","volume":"83","author":"Berard","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2018.08.030_bib13","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1001\/jama.2015.5605","article-title":"Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn","volume":"313","author":"Huybrechts","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2018.08.030_bib14","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.4088\/JCP.12f07731","article-title":"Selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"73","author":"Andrade","year":"2012","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.ajog.2018.08.030_bib15","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1056\/NEJMoa052744","article-title":"Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn","volume":"354","author":"Chambers","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2018.08.030_bib16","doi-asserted-by":"crossref","first-page":"h3190","DOI":"10.1136\/bmj.h3190","article-title":"Specific SSRIs and birth defects: Bayesian analysis to interpret new data in the context of previous reports","volume":"351","author":"Reefhuis","year":"2015","journal-title":"BMJ"},{"issue":"5","key":"10.1016\/j.ajog.2018.08.030_bib17","doi-asserted-by":"crossref","first-page":"e001681","DOI":"10.1161\/JAHA.114.001681","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and the risk of congenital heart defects: a meta-analysis of prospective cohort studies","volume":"4","author":"Wang","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.ajog.2018.08.030_bib18","doi-asserted-by":"crossref","first-page":"h1798","DOI":"10.1136\/bmj.h1798","article-title":"Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design","volume":"350","author":"Furu","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.08.030_bib19","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0095-5108(18)30039-3","article-title":"Pulmonary vascular biology during neonatal transition","volume":"26","author":"Lakshminrusimha","year":"1999","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ajog.2018.08.030_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.reprotox.2012.04.015","article-title":"Antidepressant use in pregnancy and persistent pulmonary hypertension of the newborn (PPHN): a systematic review","volume":"34","author":"\u2019t Jong","year":"2012","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2018.08.030_bib21","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1152\/physrev.00032.2009","article-title":"Regulation of the pulmonary circulation in the fetus and newborn","volume":"90","author":"Gao","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ajog.2018.08.030_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fped.2013.00023","article-title":"Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review","volume":"1","author":"Puthiyachirakkal","year":"2013","journal-title":"Front Pediatr"},{"key":"10.1016\/j.ajog.2018.08.030_bib23","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1053\/j.semperi.2013.11.004","article-title":"Update on PPHN: mechanisms and treatment","volume":"38","author":"Nair","year":"2014","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2018.08.030_bib24","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12519-017-0056-z","article-title":"Factors relating caesarean section to persistent pulmonary hypertension of the newborn","volume":"13","author":"Babooa","year":"2017","journal-title":"World J Pediatr"},{"key":"10.1016\/j.ajog.2018.08.030_bib25","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.2165\/11634190-000000000-00000","article-title":"Early morbidity and mortality following in utero exposure to selective serotonin reuptake inhibitors: a population-based study in Western Australia","volume":"26","author":"Colvin","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ajog.2018.08.030_bib26","unstructured":"The FDA. FDA drug safety communication: selective serotonin reuptake inhibitor (SSRI) antidepressant use during pregnancy and reports of a rare heart and lung condition in\u00a0newborn babies. Available at: https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm283375.htm. Accessed Oct. 25,\u00a02017."},{"key":"10.1016\/j.ajog.2018.08.030_bib27","unstructured":"Medicines and Healthcare Products Regulatory Agency. Guidance: selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs): use and safety. Available at: https:\/\/www.gov.uk\/government\/publications\/ssris-and-snris-use-and-safety\/selective-serotonin-reuptake-inhibitors-ssris-and-serotonin-and-noradrenaline-reuptake-inhibitors-snris-use-and-safety. Accessed Jan. 15,\u00a02018."},{"key":"10.1016\/j.ajog.2018.08.030_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11920-010-0114-x","article-title":"Guidelines for the management of depression during pregnancy","volume":"12","author":"Kim","year":"2010","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.ajog.2018.08.030_bib29","unstructured":"National Institute for Health and Care Excellence (NICE). Antenatal and postnatal mental health: clinical management and service guidance. Available at: https:\/\/www.nice.org.uk\/guidance\/cg192\/chapter\/1-recommendations#treatment-decisions-advice-and-monitoring-for-women-who-are-planning-a-pregnancy-pregnant-or-in-2. Accessed Jan. 15,\u00a02018."},{"key":"10.1016\/j.ajog.2018.08.030_bib30","doi-asserted-by":"crossref","first-page":"f6932","DOI":"10.1136\/bmj.f6932","article-title":"Prenatal exposure to antidepressants and persistent pulmonary hypertension of the newborn: systematic review and meta-analysis","volume":"348","author":"Sophie","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.08.030_bib31","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2018.08.030_bib32","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, M Losos PT. Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2011. Available at: http:\/\/www.ohri.ca\/programs. Accessed September 15, 2017."},{"key":"10.1016\/j.ajog.2018.08.030_bib33","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"The\u00a0Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Wells","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ajog.2018.08.030_bib34","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.316.7129.469","article-title":"Bias in meta-analysis detected by a simple, graphical","volume":"316","author":"Stuck","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.08.030_bib35","series-title":"Review Manager (RevMan), Version 5.3","year":"2014"},{"key":"10.1016\/j.ajog.2018.08.030_bib36","unstructured":"Viechtbauer W. Meta-analysis package for R. Available at: https:\/\/cran.r-project.org\/web\/packages\/metafor\/metafor.pdf. Accessed Dec. 26,\u00a02016."},{"key":"10.1016\/j.ajog.2018.08.030_bib37","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.ajog.2018.08.030_bib38","doi-asserted-by":"crossref","unstructured":"Borenstein M, Hedges L, Rothstein H. Metaanalysis fixed effect vs random effects. Test. https:\/\/doi.org\/10.1002\/9780470743386. Accessed December 25, 2017.","DOI":"10.1002\/9780470743386"},{"key":"10.1016\/j.ajog.2018.08.030_bib39","doi-asserted-by":"crossref","first-page":"d549","DOI":"10.1136\/bmj.d549","article-title":"Interpretation of random effects meta-analyses","volume":"342","author":"Riley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.08.030_bib40","unstructured":"Del-Re A. Compute effect sizes. Available at: https:\/\/cran.r-project.org\/web\/packages\/compute.es\/compute.es.pdf. Accessed Sept. 26,\u00a02017."},{"key":"10.1016\/j.ajog.2018.08.030_bib41","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.ajog.2018.08.030_bib42","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12874-015-0060-8","article-title":"Ranking treatments in frequentist network meta-analysis works without resampling methods","volume":"15","author":"R\u00fccker","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ajog.2018.08.030_bib43","unstructured":"Rucker G, Schwarzer G, Krahn U, Konig J. Network Meta-Analysis using Frequentist Methods. Available at: https:\/\/cran.r-project.org\/web\/packages\/netmeta\/netmeta.pdf. Accessed March 30, 2018."},{"key":"10.1016\/j.ajog.2018.08.030_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0030-1262507","article-title":"Persistent pulmonary hypertension of the newborn is associated with mode of delivery and not with maternal use of selective serotonin reuptake inhibitors","volume":"28","author":"Wilson","year":"2011","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2018.08.030_bib45","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/pds.1570","article-title":"Maternal use of selective serotonin re-uptake inhibitors and persistent pulmonary hypertension of the newborn","volume":"17","author":"Kallen","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2018.08.030_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.1710","article-title":"Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn","volume":"18","author":"Andrade","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2018.08.030_bib47","first-page":"S91","article-title":"Association between maternal exposure to antidepressant drugs and persistent pulmonary hypertension of the newborn (PPHN) in the mother-baby linked records in the UK-based General Practice Research Database (GPRD): preliminary results","volume":"18","author":"Hammad","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2018.08.030_bib48","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4065\/84.1.23","article-title":"Congenital heart disease associated with selective serotonin reuptake inhibitor use during pregnancy","volume":"84","author":"Wichman","year":"2009","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ajog.2018.08.030_bib49","doi-asserted-by":"crossref","first-page":"d8012","DOI":"10.1136\/bmj.d8012","article-title":"Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries","volume":"344","author":"Kieler","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2018.08.030_bib50","doi-asserted-by":"crossref","first-page":"e20160181","DOI":"10.1542\/peds.2016-0181","article-title":"Neonatal morbidity after maternal use of antidepressant drugs during pregnancy","volume":"138","author":"N\u00f6rby","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajog.2018.08.030_bib51","first-page":"JC5","article-title":"SSRI use in late pregnancy was associated with increased persistent pulmonary hypertension in newborns","volume":"156","author":"Kieler","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ajog.2018.08.030_bib52","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/jech.44.3.179","article-title":"Bias in case-control studies. A review","volume":"44","author":"Kopec","year":"1990","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.ajog.2018.08.030_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199700321-00003","article-title":"Clinically relevant pharmacology of selective serotonin reuptake inhibitors","volume":"32","author":"Preskorn","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ajog.2018.08.030_bib54","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/1389200023338017","article-title":"Selective serotonin reuptake inhibitors and cytochrome P-450 mediated drug-drug interactions: an update","volume":"3","author":"Hemeryck","year":"2002","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.ajog.2018.08.030_bib55","doi-asserted-by":"crossref","first-page":"e272","DOI":"10.1542\/peds.2006-3037","article-title":"Risk factors for persistent pulmonary hypertension of the newborn","volume":"120","author":"Hern\u00e1ndez-D\u00edaz","year":"2007","journal-title":"Pediatrics"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818307099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937818307099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:20:10Z","timestamp":1757589610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937818307099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S0002937818307099"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2018.08.030","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal exposure to selective serotonin reuptake inhibitors and serotonin norepinephrine reuptake inhibitors and risk for persistent pulmonary hypertension of the newborn: a systematic review, meta-analysis, and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2018.08.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}